Deal of the Day — limited-time pharmacy picks!
Pegstim 6mg Injection PFS

Pegstim 6mg Injection PFS

Prescription requiredRx Required
Refrigerated 2–8°C · Online payment only

Salt Composition: Pegfilgrastim (6mg)

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

1 Inj

About The Product

Pegstim 6mg Injection PFS contains the active ingredient Pegfilgrastim.

Description

Pegstim 6mg Injection PFS contains Pegfilgrastim (6mg) as an active ingredient. It is prescribed to prevent the infection after chemotherapy.

This injection is a growth factor that promotes bone marrow to produce white blood cells as these cells protect the body against infections. Dosage determined as per the overall health condition of the patient.

It should be given by healthcare professional only do not self administer this injection. Don't take more than the recommended dose.​

Uses

  • Prevention of Infections after chemotherapy

Side Effects

Most side effects of Pegstim 6mg Injection PFS do not require medical attention as they may disappear as your body adjusts to the medicine. In case these side effects become worse, consult your doctor immediately.

Common side effects include:

  • Bone pain
  • Joint pain
  • Headache
  • Nausea
  • Low blood platelets
  • Muscle pain
  • Back pain
  • Pain in extremities
  • Injection site pain

How To Use

  • Pegstim 6mg is available in injection form and is advised to be taken as per the doctor's prescription. It should be administered by a doctor or experienced nurse under strict medical supervision.
  • Taking this injection in the wrong way may give you severe side effects. In case of overdose, contact your healthcare provider or doctor and they will provide you with medical attention.

How It Works

  • Pegstim 6mg Injection PFS contains Pegfilgrastim (6mg) as an active ingredient.
  • This injection is a growth factor that promotes bone marrow to produce white blood cells as these cells protect the body against infections. Dosage determined as per the overall health condition of the patient.​​

Safety Advice

Alcohol
The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Pegstim 6mg Injection PFS.
Pregnancy
Do not take Pegstim 6mg Injection PFS during pregnancy, as it is a highly unsafe medicine for the fetus. Also, this medicine is especially designed to treat male-related cancers.
Breast Feeding
Pegstim 6mg Injection PFS is safe to use while breastfeeding, if prescribed by the doctor. No dosage adjustment is necessary for this tablet as limited data is available that shows significant risk.
Driving
Pegstim 6mg Injection PFS is usually consider safe in case of driving as it does not affect your ability to drive
Kidney
Pegstim 6mg Injection PFS is safe for use in kidney disease. No dosage adjustment is necessary for this Tablet.
Liver
Consumption of Pegstim 6mg Injection PFS should be avoided without informing the doctor if you have any liver-related issues.

FAQs

Avoid the consumption of Pegstim 6mg Injection PFS if you have any liver related issue without consulting the doctor, however it is safe to use in kidney related issues after doctor prescription.

References

  • Weycker, D., Malin, J., Barron, R., Edelsberg, J., Kartashov, A., & Oster, G. (2012). Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy. American Journal of Clinical Oncology, 35(3), 267-274. https://pubmed.ncbi.nlm.nih.gov/21378538/
  • Yang, B. B., Savin, M. A., & Green, M. (2013). Prevention of chemotherapy-induced neutropenia with pegfilgrastim: pharmacokinetics and patient outcomes. Chemotherapy, 58(5), 387-398. https://pubmed.ncbi.nlm.nih.gov/23296266/
  • WALADKHANI, A. R. (2004). Pegfilgrastim: a recent advance in the prophylaxis of chemotherapy‐induced neutropenia. European Journal of Cancer Care, 13(4), 371-379. https://pubmed.ncbi.nlm.nih.gov/15305906/
  • Lambertini, M., Ferreira, A. R., Del Mastro, L., Danesi, R., & Pronzato, P. (2015). Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors. Expert Opinion on Biological Therapy, 15(12), 1799-1817. https://pubmed.ncbi.nlm.nih.gov/26488491/
  • Zamboni, W. C. (2003). Pharmacokinetics of pegfilgrastim. Pharmacotherapy: The journal of human pharmacology and drug therapy, 23(8P2), 9S-14S. https://pubmed.ncbi.nlm.nih.gov/12921217/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026